|Day Low/High||125.65 / 127.31|
|52 Wk Low/High||91.53 / 139.04|
Global equity rally takes a breather.
Bank and commodity stocks dragged European benchmarks lower Tuesday as mining stocks pared Monday's gains and the second-quarter earnings season got underway.
The Berkeley site, which includes Bayer's global biotechnology development and product supply organizations, is the company's single plant that manufactures and distributes its Hemophilia A treatments
The first confirmed case of the plague this year was diagnosed in June when a 63-year-old man contracted the disease.
The biggest U.S. grocer wants winter melons to taste just as sweet as the summer ones.
European benchmarks rose Tuesday as fallers from the previous session paired losses and concerns over political risks receded, in favor of a renewed focus on economic data and monetary policy.
The sale stands to potentially be valued at $2.5 billion to $3 billion.
European benchmarks were roundly higher at the close Friday following what was a volatile session for London, with British politics delivering yet another upset to pundits and pollsters alike.
Bayer is offering 1 billion euros of bonds exchangeable into Covestro shares maturing in 2020.
European stocks fell Tuesday as investors shunned commodities and other risk stocks on a cocktail of concerns, ranging from the Middle East to domestic terrorism and politics.
While causing upset among politicians and some business leaders, President Donald Trump's withdrawal of the U.S. from the Paris Agreement helped boost stock prices across the chemicals and automotive sectors.
The divestment was part of a divestment required by South Africa's competition committee.
European stocks fell for the first session in nearly a week Thursday as investors reacted to a mixed set of regional corporate earnings.
Bayer shares rose to the top of the German leaderboard after reporting better-than-excepted first quarter earnings that were boosted by leap in sales of the group's stroke prevention treatment.
Two sexual harassment scandals might devastate other brands, but not so with Fox News.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
With more than 70 advertisers leaving the show amid a generational shift in leadership, the Murdoch family may soon decide to cancel 'The O'Reilly Factor,' according to a report.
The media giant has asked the same law firm that conducted an investigation into former Fox News CEO Roger Ailes, who was ousted in July.
ChemChina and Switzerland's Syngenta win conditional approval from the European Commission for their $43 billion Wednesday.
ChemChina must sell its U.S. paraquat, abamectin and chlorothalonil crop protection businesses to California agrochemical company AMVAC.
The German DAX led Europe's markets higher Thursday with solid gains in airlines, autos and chemicals
President Trump's socially conservative administration has vowed to crack down on marijuana, but here's why pot investors shouldn't worry.
European stocks were weaker and bonds higher as unease returned to markets.
Corporate earnings and resurgent concerns over politics hit European benchmarks on Thursday.
Bayer isn't expecting their deal for Monsanto to be derailed by regulatory issues, despite recent delays.